Stephanie Piper focuses her practice in the area of patent litigation and has experience guiding clients through every stage of a litigation from performing pre-suit evaluations, initiating suits, and pursuing fact and expert discovery to trial on the merits and appeals. She also advises clients on freedom to operate analyses and related diligence matters. She has significant experience representing biopharmaceutical companies in complex Hatch-Waxman litigations as well as experience representing medical device and biotechnology companies.
While in law school, Stephanie served as the Notes Editor for the Columbia Science and Technology Law Review.
DLA Piper is a global law firm operating through various separate and distinct legal entities. For further information about these entities and DLA Piper's structure, please refer to the Legal Notices page of this website. All rights reserved. Attorney advertising.
Unsolicited e-mails and information sent to DLA Piper or the independent DLA Piper Relationship firms will not be considered confidential, may be disclosed to others, may not receive a response, and do not create a lawyer-client relationship with DLA Piper or any of the DLA Piper Relationship firms. Please do not include any confidential information in this message. Also, please note that our lawyers do not seek to practice law in any jurisdiction in which they are not properly permitted to do so.